+49 2066 50687-70

Heiner Dreismann joins Noscendo’s Board of Directors

Duisburg, October 5, 2021 – Noscendo GmbH, a leading diagnostic company for identification and assessment of bloodstream associated pathogens and other infections announced today the addition of Heiner Dreismann, former President and CEO of Roche Molecular Systems, to...

A Case Report of Invasive Cerebral Aspergillosis

Next-Generation Sequencing-Based Decision Support for Intensivists in Difficult-to-Diagnose Disease States. Aspergillus spp. are widespread environmental pathogens that can induce invasive aspergillosis, especially in immunocompromised patients. An 86-year-old female...

Mission: Saving patient lives

Labor Dr. Limbach Heidelberg signs cooperation agreement with Noscendo Noscendo is committed to supporting physicians, clinics and laboratories in their daily work in the field of pathogen detection and to provide therapy-relevant results that directly benefit...

Faster pathogen identification with new method

Mainz, 14.05.2020. In hospitals in Germany, infections are one of the greatest challenges. So-called sepsis, colloquially also known as blood poisoning, accounts for a major portion of these infections. According to a study by Jena University Hospital, nationwide...

Information for physicians

More precise diagnostics – more knowledge: Find out more about the clinical use of DISQVER!

How DISQVER works

Information for medical disciplines



Read more about Noscendo and DISQVER or visit us at trade fairs and conferences!

All News





DISQVER together – get to know Noscendo!



Advisory Board